Advertisement

Apoptosis in Normal and Pathological Vessels

  • Ziad Mallat
  • Alain Tedgui
Part of the Basic Science for the Cardiologist book series (BASC, volume 1)

Abstract

Vascular pathologists have long been intrigued by the observation of a form of active vascular cell death within the arterial wall in atherosclerosis [1, 2] or during normal aging [3] in the absence of overt necrosis. Rational explanations for these observations may now be at hand after the description by Kerr and colleagues in the early 1970s of a novel form of cell death distinct from necrosis, which they designated “apoptosis” (from the Greek word for falling) [4]. It has since been increasingly recognized that apoptosis may be involved in a number of critical events occurring during normal development and may play a key role in a wide variety of diseases [5].

Keywords

Vascular Endothelial Growth Factor Vascular Smooth Muscle Cell Atherosclerotic Plaque Human Endothelial Cell Arterioscler Thromb Vasc Biol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Virchow R. Cellular Pathology as Based Upon Physiological and Pathological Histology, ed 2. Birmingham, AL, Classics of Medicine Library, 1858: 361.Google Scholar
  2. 2.
    Thomas WA, Reiner JM, Florentin FA, Lee KT, Lee WM. Population dynamics of arterial smooth muscle cells. V. Cell proliferation and cell death during initial three months in atherosclerotic lesions induced in swine by hypercholesterolemic diet and intimai trauma. Exp Mol Pathol. 1976;24:360–374.PubMedGoogle Scholar
  3. 3.
    Cliff WJ. The aortic tunica media in aging rats. Exp Mol Pathol. 1970;13:172–189.PubMedGoogle Scholar
  4. 4.
    Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J cancer. 1972;26:239–257.PubMedGoogle Scholar
  5. 5.
    Hetts SW. To die or not to die. An overview of apoptosis and its role in disease. JAMA. 1998;279:300–307.PubMedGoogle Scholar
  6. 6.
    Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie RCA, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545–1556.PubMedGoogle Scholar
  7. 7.
    Majno G, Joris I. Apoptosis, oncosis, and necrosis. Am J Pathol. 1995;146:3–15.PubMedGoogle Scholar
  8. 8.
    Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res. 1998;82:1111–1129.PubMedGoogle Scholar
  9. 8bis.
    Green DR. Apoptotic pathways: the roads to ruin. Cell. 1998;94:695–698.PubMedGoogle Scholar
  10. 9.
    Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994;179:1317–1330.PubMedGoogle Scholar
  11. 10.
    Tan EM. Autoimmunity and apoptosis. J Exp Med. 1994; 179:1083–1086.PubMedGoogle Scholar
  12. 11.
    Rosen A, Casciola-Rosen L, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med. 1995;181:1557–1561.PubMedGoogle Scholar
  13. 12.
    Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunology Today. 1997; 18:44–51.PubMedGoogle Scholar
  14. 13.
    Golstein P. Controlling cell death. Science. 1997;275:1081–1082.PubMedGoogle Scholar
  15. 14.
    Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1311.PubMedGoogle Scholar
  16. 15.
    Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305–1308.PubMedGoogle Scholar
  17. 16.
    Hartwell LH, Kastan MB. Cell cycle control and cancer. Science. 1994;266:1821–1828.PubMedGoogle Scholar
  18. 17.
    Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997;389:300–305.PubMedGoogle Scholar
  19. 18.
    Green D, Kroemer G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 1998;8:267–271.PubMedGoogle Scholar
  20. 19.
    Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312–1316.PubMedGoogle Scholar
  21. 20.
    Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 1997;3:614–620.PubMedGoogle Scholar
  22. 21.
    Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37–43.PubMedGoogle Scholar
  23. 22.
    Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 1998;391:96–99.PubMedGoogle Scholar
  24. 23.
    Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;391:43–50.PubMedGoogle Scholar
  25. 24.
    Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol. 1992;149:4029–4035.PubMedGoogle Scholar
  26. 25.
    Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today. 1993;14:131–136.PubMedGoogle Scholar
  27. 26.
    Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 1998;392:505–509.PubMedGoogle Scholar
  28. 27.
    Kaiser D, Freyberg MA, Friedl P. Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem Biophys Res Commun. 1997;231:586–590.PubMedGoogle Scholar
  29. 28.
    Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med. 1997; 185:601–607.PubMedGoogle Scholar
  30. 29.
    Dimmeler S, Assmus B, Hermann C, Haendeler J, Zeiher AM. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res. 1998;83:334–341.PubMedGoogle Scholar
  31. 30.
    Dimmeler S, Haendeler J, Rippmann V, Nehls M, Zeiher AM. Shear stress inhibits apoptosis of human endothelial cells. Febs Lett. 1996;399:71–74.PubMedGoogle Scholar
  32. 31.
    Hermann C, Zeiher AM, Dimmeler S. Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler Thromb Vasc Biol. 1997;17:3588–3592.PubMedGoogle Scholar
  33. 32.
    Hessler JL, Robertson AL, Chisolm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells inculture. Atherosclerosis. 1979;32:213–229.PubMedGoogle Scholar
  34. 33.
    Lizard G, Deckert V, Dubrez L, Moisant M, Gambert P, Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am J Pathol. 1996;148:1625–1638.PubMedGoogle Scholar
  35. 34.
    Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: A mechanistic clue to the response to injury’ hypothesis. Circulation. 1997;95:1760–1763.PubMedGoogle Scholar
  36. 35.
    Escargueil-Blanc I, Meilhac O, Pieraggi M-T, Arnal J-F, Salvayre R, Nègre-Salvayre A. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway: prevention by aurintricarboxylic acid. Arterioscler Thromb Vasc Biol. 1997; 17:331–339.PubMedGoogle Scholar
  37. 36.
    Harada-Shiba M, Kinoshita M, Kamido H, Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem. 1998;273:9681–9687.PubMedGoogle Scholar
  38. 37.
    Lindner H, Holler E, Ertl B, Multhoff G, Schreglmann M, Klauke I, Schultz-Hector S, Eissner G. Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. Blood. 1997;89:1931–1938.PubMedGoogle Scholar
  39. 38.
    Haendeler J, Zeiher AM, Dimmeler S. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Kur J Pharmacol. 1996;317:407–411.Google Scholar
  40. 39.
    Karsan A, Yee E, Kaushansky K, Harlan JM. Cloning of a human Bcl-2 homologue: Inflammatory cytokines induce human Al in cultured endothelial cells. Blood. 1996;87:3089–3096.PubMedGoogle Scholar
  41. 40.
    Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-KappaB. Science. 1996, 274:787–789.PubMedGoogle Scholar
  42. 41.
    Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards III CK, Schuchman EH, Fuks Z, Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med. 1997;186:1831–1841.PubMedGoogle Scholar
  43. 42.
    Howard M, Muchamel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. 1993;177:1205–1208.PubMedGoogle Scholar
  44. 43.
    Meredith J, Fazeli B, Schwartz M. The extracellular matrix as a survival factor. Mol Biol Cell. 1993;4:953–961.PubMedGoogle Scholar
  45. 44.
    Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol. 1994; 127:537–546.PubMedGoogle Scholar
  46. 45.
    Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu TH, Klier G, Cheresh DA. Integrin alpha(v)beta(3) antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157–1164.PubMedGoogle Scholar
  47. 46.
    Stromblad S, Becker JC, Yebra M, Brooks PC, Cheresh DA. Suppression of p53 and p21 expression by vascular cell integrin avβ3 during angiogenesis in vivo. J Clin Invest. 1996, 98:426–433.PubMedGoogle Scholar
  48. 47.
    Rüegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeune FJ. Evidence for the involvement of endothelial cell integrin avβ3 in the disruption of the tumor vasculature induced by TNF and IFN-g. Nat Med. 1998;4:408–413.PubMedGoogle Scholar
  49. 48.
    Alon T, Hemo I, Itin A, Pe’er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1:1024–1028.PubMedGoogle Scholar
  50. 49.
    Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA. 1997;94:8761–8766.PubMedGoogle Scholar
  51. 50.
    Watanabe Y, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation. Exp Cell Res. 1997;233:340–349.PubMedGoogle Scholar
  52. 51.
    Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 1995, 55:5687–5692.PubMedGoogle Scholar
  53. 52.
    Karsan A. Tumor necrosis factor and endothelial cell death. Trends Cardiovasc Med. 1998;8:19–24.Google Scholar
  54. 53.
    Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and Al in vascular endothelial cells. J Biol Chem. 1998;273:13313–13316.PubMedGoogle Scholar
  55. 54.
    Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2 dependent and independent mechanisms. Am J Pathol. 1997;151:1775–1784.PubMedGoogle Scholar
  56. 55.
    Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation. 1997;95:1505–1514.PubMedGoogle Scholar
  57. 56.
    Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266–2274.PubMedGoogle Scholar
  58. 57.
    Fox JC, Shanley JR. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem. 1996;271:12578–12584.PubMedGoogle Scholar
  59. 58.
    Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang LN, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994, 94:978–984.PubMedGoogle Scholar
  60. 59.
    von der Leyen H, Gibbons GH, Morishita R, Lewis NP, Zhang L, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Nail Acad Sci USA. 1995;92:1137–1141.Google Scholar
  61. 60.
    Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79:748–756.PubMedGoogle Scholar
  62. 61.
    Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vase Biol. 1996; 16:19–27.Google Scholar
  63. 62.
    Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:2200–2208.PubMedGoogle Scholar
  64. 63.
    Leszczynski D, Zhao Y, Luokkamäki M, Foegh ML. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol. 1994;145:1265–1270.PubMedGoogle Scholar
  65. 64.
    Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1,-2 or-3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. J Clin Invest. 1998; 101:1478–1487.PubMedGoogle Scholar
  66. 65.
    Joringe S, Crisby M, Thyberg J, Nilsson J. DNA fragmentation and ultrustructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler Thromb Vasc Biol. 1997; 17:2225–2231.Google Scholar
  67. 66.
    Nishio E, Watanabe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and BCL-2 protein downregulation. Biochem Biophys Res Commun. 1996;226:928–934.PubMedGoogle Scholar
  68. 67.
    Tsai JC, Jain M, Hsieh CM, Lee WS, Yoshizumi M, Patterson C, Perrella MA, Cooke C, Wang H, Haber E, Schlegel R, Lee ME. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem. 1996;271:3667–3670.PubMedGoogle Scholar
  69. 68.
    Bennett MR, Evan GI, Newby AC. Deregulated expression of the c myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-g, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res. 1994;74:525–536.PubMedGoogle Scholar
  70. 69.
    Bennett MR, Evan GI, Schwartz SM. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and-independent pathways. Circ Res. 1995;77:266–273.PubMedGoogle Scholar
  71. 70.
    Parkes JL, Cardell RR, Hubbard FCJ, Hubbard D, Meltzer A, Penn A. Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. Am J Pathol. 1991;138:765–775.PubMedGoogle Scholar
  72. 71.
    Bennett MR, Littlewood TD, Schwartz SM, Weissberg PL. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res. 1997;81:591–599.PubMedGoogle Scholar
  73. 72.
    Bennett MR, Macdonald K, Chan SW, Boyle JJ, Weissberg PL. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 1998;82:704–712.PubMedGoogle Scholar
  74. 73.
    Lang RA, Bishop JM. Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell. 1993;74:453–462.PubMedGoogle Scholar
  75. 74.
    Meeson A, Palmer M, Calfon M, Lang R. A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Development. 1996; 122:3929–3938.PubMedGoogle Scholar
  76. 75.
    Slomp J, Gittenbergerdegroot AC, Glukhova MA, Vanmunsteren JC, Kockx MM, Schwartz SM, Koteliansky VE. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vascr Biol. 1997;17:1003–1009.Google Scholar
  77. 76.
    Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168–175.PubMedGoogle Scholar
  78. 77.
    Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69:119–128.PubMedGoogle Scholar
  79. 78.
    Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703–2711.PubMedGoogle Scholar
  80. 79.
    Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-lβ-converting enzyme. Am J Pathol. 1995;147:251–266.PubMedGoogle Scholar
  81. 80.
    Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267–277.PubMedGoogle Scholar
  82. 81.
    Kockx MM, Demeyer GRY, Muhring J, Butt H, Bultinck J, Herman AG. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis. 1996;120:115–124.PubMedGoogle Scholar
  83. 82.
    Björkerud S, Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 1996; 149:367–380.PubMedGoogle Scholar
  84. 83.
    Hegyi L, Skepper JN, Cary NR, Mitchinson MJ. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol. 1996; 180:423–442.PubMedGoogle Scholar
  85. 84.
    Mallat Z, Ohan J, Lesèche G, Tedgui A Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 1997;96:424–428.PubMedGoogle Scholar
  86. 85.
    Cai W, Devaux B, Schaper W, Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis. 1997;131:177–186.PubMedGoogle Scholar
  87. 86.
    Kockx MM, De Meyer GRY, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97:2307–2315.PubMedGoogle Scholar
  88. 87.
    Bauriedel G, Schluckebier S, Hutter R, Welsch U, Kandolf R, Lüderitz B, Prescott MF. Apoptosis in restenosis versus stable-angina atherosclerosis. Implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol. 1998;18:1132–1139.PubMedGoogle Scholar
  89. 88.
    Mallat Z, Heymes C, Ohan J, Faggin E, Lesèche G, Tedgui A Expression of interleukin-10 in human atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol. 1999;(in press).Google Scholar
  90. 89.
    Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc NatlAcad Sci USA. 1990;87:4600–4604.Google Scholar
  91. 90.
    Brandi R, Richter T, Haug K, Wilhelm MG, Maurer PC, Nathrath W. Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation. 1997, 96:3360–3368.Google Scholar
  92. 91.
    Dong C, Wilson JE, Winters GL, B.M. M. Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest. 1996;74:921–931.PubMedGoogle Scholar
  93. 92.
    Han DKM, Wright ME, Dixit VM, Pruit R, Son Soe M, Lynch DH, Schwartz SM. Evidence for escape of apoptosis by a loss of Fas in atherosclerotic plaque smooth muscle cells. Circulation. 1996;94(suppl I):1–397.Google Scholar
  94. 93.
    Miossec C, Dutilleul V, Fassy F, Diuhercend A. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J Biol Chem. 1997;272:13459–13462.PubMedGoogle Scholar
  95. 94.
    Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, et al. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet. 1994;343:881–886.PubMedGoogle Scholar
  96. 95.
    Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med. 1998;4:222–227.PubMedGoogle Scholar
  97. 96.
    Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood. 1997;89:2429–2442.PubMedGoogle Scholar
  98. 97.
    Flynn PD, Byrne CD, Baglin TP, Weissberg PL, Bennett MR. Thrombin generation by apoptotic vascular smooth muscle cells. Blood. 1997;89:4378–4384.PubMedGoogle Scholar
  99. 98.
    Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry. 1986;25:4007–4020.PubMedGoogle Scholar
  100. 99.
    Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. A role for apoptosis in plaque thrombogenicity. Circulation. 1999;99:(in press).Google Scholar
  101. 100.
    Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997;95:981–987.PubMedGoogle Scholar
  102. 101.
    Bochaton-Piallat ML, Gabbiani F, Redard M, Desmoulière A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimai thickening. Am J Pathol. 1995;146:1059–1064.PubMedGoogle Scholar
  103. 102.
    Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391–394.PubMedGoogle Scholar
  104. 103.
    Steg PG, Tahlil O, Aubailly N, Caillaud JM, Dedieu JF, Berthelot K, Le Roux A, Feldman L, Perricaudet M, Denefle P, Branellec D. Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. Circulation. 1997, 96:408–411.PubMedGoogle Scholar
  105. 104.
    Sata M, Perlman H, Muruve DA, Silver M, Ikebe M, Libermann TA, Oettgen P, Walsh K. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci USA. 1998;95:1213–1217.PubMedGoogle Scholar
  106. 105.
    Hamet P, Moreau P, Dam TV, Orlov SN, Tea BS, Deblois D, Tremblay J. The time window of apoptosis: A new component in the therapeutic strategy for cardiovascular remodeling. J Hypertens. 1996;14:S65–S70.Google Scholar
  107. 106.
    Gobe G, Browning J, Howard T, Hogg N, Winterford C, Cross R. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. J Struct Biol. 1997;118:63–72.PubMedGoogle Scholar
  108. 107.
    Diez J, Panizo A, Hernandez M, Pardo J. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats? Hypertension. 1997;29:776–780.PubMedGoogle Scholar
  109. 108.
    Deblois D, Tea BS, Dam TV, Tremblay J, Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 1997;29:340–349.PubMedGoogle Scholar
  110. 109.
    Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97:2883–2890.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Ziad Mallat
    • 1
  • Alain Tedgui
    • 1
  1. 1.Lariboisière HospitalInserm U141ParisFrance

Personalised recommendations